Of note, changes in the TIL repertoire observed in lymphoma models resemble those originally described in mammary tumors growing in Camkk2-/- compared to WT mice (26), indicating that in these two models of tumors deletion of Camkk2 in the host trigger a similar anti-tumor effector mechanism. Here, CAMKK2 is linked to breast cancer.